News Conference News EuroPCR 2019 Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE Michael O'Riordan May 22, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Daily News How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting Shelley Wood February 26, 2019
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Daily News Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF L.A. McKeown November 02, 2018
News Conference News TCT 2018 Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure Todd Neale September 23, 2018
News Industry News Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial August 27, 2018
News Daily News Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF Todd Neale February 20, 2018
News Daily News High-Sensitivity Troponin May Help Uncover Heart Failure Risk Todd Neale January 11, 2018
News Daily News Exercise Study Hints at Volume, Intensity Levels Needed to Improve Cardiac Fitness in Middle Age Shelley Wood January 10, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017
News Industry News Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure November 14, 2017
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
Presentation AHA 2016 Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial Presenter: David M Kaye November 15, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Industry News Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure June 27, 2016
News Industry News Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study May 12, 2016